Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management

Following kidney transplantation (KT), cytomegalovirus (CMV) infection remains an important challenge. Both prophylactic and preemptive antiviral protocols are used for CMV high-risk kidney recipients (donor seropositive/recipient seronegative; D+/R–). We performed a nationwide comparison of the 2 s...

Descripción completa

Detalles Bibliográficos
Autores principales: Blom, Kjersti B., Birkeland, Grete K., Midtvedt, Karsten, Jenssen, Trond G., Reisæter, Anna V., Rollag, Halvor, Hartmann, Anders, Sagedal, Solbjørg, Sjaastad, Ivar, Tylden, Garth, Njølstad, Gro, Nilsen, Einar, Christensen, Andreas, Åsberg, Anders, Birkeland, Jon A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Clinical Science—General
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358437/
https://www.ncbi.nlm.nih.gov/pubmed/37211633
http://dx.doi.org/10.1097/TP.0000000000004615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358437/
https://www.ncbi.nlm.nih.gov/pubmed/37211633
http://dx.doi.org/10.1097/TP.0000000000004615

Ejemplares similares